Viral Disease Articles & Analysis
38 news found
Infectious diseases are disorders caused by organisms — such as bacteria, viruses, or parasites. A vaccine is a specialized biological formulation that triggers the immune system to recognize and activate protective responses against specific disease-causing agents. With the global landscape of infectious diseases continually evolving, ...
These variations are driven by RNA polymerase as it replicates the viral genome. In addition, when different subtypes infect the same host cell, genetic recombination occurs between them to further generate new strains of the virus. ...
Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) are major global health threats. Their interaction worsens disease severity, as HIV reduces CD4+ T cells, making individuals more vulnerable to TB. ...
Fungal Disease Awareness Week (FDAW) kicks off today and runs through the 22nd. The Centers for Disease Control and Prevention (CDC) created FDAW to highlight the importance of recognizing, treating, and preventing serious fungal diseases. ...
Chimeric also receives exclusive global rights to the CORE-NK platform for immune disorders and viral infectious diseases. Chimeric’s exclusive global license from CWRU covers patent rights, knowhow, and biological materials in relation to therapeutic products for the NKF feeder cell line and CORE-NK manufacturing process in the fields of use, including ...
Chimeric also receives exclusive global rights to the CORE-NK platform for immune disorders and viral infectious diseases. “We are excited to continue building on our collaboration with CWRU with the definitive license agreement for the CORE-NK platform,” said Jennifer Chow, CEO and Managing Director of Chimeric. ...
XPhyto’s pipeline of biosensor screening products for inflammatory, bacterial and viral infectious diseases includes stomatitis, periimplantitis, periodontitis, group A strep, influenza A, and covid-19. ...
The company expects to provide further updates on its oral health and infectious disease screening test programs in the coming weeks. XPhyto’s pipeline of biosensor screening products for inflammatory, bacterial and viral infectious diseases includes stomatitis, periimplantitis, periodontitis, group A strep, influenza A, and covid-19. ...
According to the report of World Health Organization (WHO) on May 21, more than 120 confirmed or suspected cases of monkeypox, a rare viral disease seldom detected outside Africa, have been reported in at least 12 non-epidemic countries around the world, including more than 20 confirmed cases in Portugal, Spain and the UK. ...
The Toronto-based research reports a decrease of viral infectivity of 90% of SARS-CoV-2 patient samples using Ondine’s nasal antimicrobial photodynamic disinfection (aPDT), with 70% of patient samples completely inactivated from a single 5-minute treatment. ...
At baseline, 34 patients had a viral load below 10,000 copies/mL. The median viral load in these 34 patients was 2,042 copies/mL on Day 1. ...
ByKalaris
The ModeX product portfolio includes cancer immunotherapies that combine four specificities into one protein to improve targeting and immune killing, as well as masking or “stealth” technology to improve tumor-specific killing and reduce side effects. For viral diseases, the lead targets of a broad and potent multi-specific antibody portfolio include ...
As 90% of allo-HCT patients reactivate at least one of these viruses, there is a large global market opportunity for the prevention of devastating viral diseases, with an estimated addressable patient population of 40,000 allo-HCT patients annually. ...
ByKalaris
Posoleucel has the potential to fundamentally transform the landscape for allo-HCT by preventing life-threatening viral diseases and infections, either as a prophylactic therapy in high-risk patients or as a preemptive therapy in patients who have already reactivated one or more of the six viruses targeted by posoleucel. As 90% of allo-HCT patients reactivate at ...
ByKalaris
About AlloVir AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T ...
ByKalaris
As 90% of allo-HCT patients reactivate at least one of these viruses, there is a large global market opportunity for the prevention of devastating viral diseases, with an estimated addressable patient population of 40,000 allo-HCT patients annually. ...
ByKalaris
Prior to that, he was Vice President, Business Development, at Receptor BioLogix (Palo Alto, CA), a biopharmaceutical company focused on the discovery and development of novel biotherapeutics for the treatment of cancer and autoimmune diseases, Senior Director, Business Development, at Anesiva, Inc. (fka Corgentech, South San Francisco, CA), a developer of drugs for treating pain ...
Dr Arun Chandavarkar, Managing Director, Biocon Biologics Ltd., says the structure of the strategic alliance with Serum Institute Life Sciences provides Biocon Biologics with an asset light and accelerated entry into the often overlooked infectious diseases segment. Having established capabilities and a track record of success in biologics, Biocon Biologics’ foray into ...
ByBiocon
About AlloVir AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells ...
ByKalaris
The preliminary data set demonstrated a substantial reduction in the expected rate of clinically significant viral infections or diseases and facilitates an accelerated path to Phase 3 development, which has been agreed to in principle by the U.S. ...
ByKalaris